Thandapani et al. 2021 (PRJNA704908)

General Details

Title Valine tRNA biogenesis and bioavailability regulates mitochondrial complex I levels in acute leukemia [Ribo-Seq]
Organism
Number of Samples 8
Release Date 2021/02/25 00:00
Sequencing Types
Protocol Details

Study Links

Repository Details

SRA SRP308208
ENA SRP308208
GEO
BioProject PRJNA704908

Publication

Title
Authors Thandapani P,Kloetgen A,Witkowski MT,Glytsou C,Lee AK,Wang E,Wang J,LeBoeuf SE,Avrampou K,Papagiannakopoulos T,Tsirigos A,Aifantis I
Journal Nature
Publication Date 2022 Jan
Abstract Although deregulation of transfer RNA (tRNA) biogenesis promotes the translation of pro-tumorigenic mRNAs in cancers 1,2 , the mechanisms and consequences of tRNA deregulation in tumorigenesis are poorly understood. Here we use a CRISPR-Cas9 screen to focus on genes that have been implicated in tRNA biogenesis, and identify a mechanism by which altered valine tRNA biogenesis enhances mitochondrial bioenergetics in T cell acute lymphoblastic leukaemia (T-ALL). Expression of valine aminoacyl tRNA synthetase is transcriptionally upregulated by NOTCH1, a key oncogene in T-ALL, underlining a role for oncogenic transcriptional programs in coordinating tRNA supply and demand. Limiting valine bioavailability through restriction of dietary valine intake disrupted this balance in mice, resulting in decreased leukaemic burden and increased survival in vivo. Mechanistically, valine restriction reduced translation rates of mRNAs that encode subunits of mitochondrial complex I, leading to defective assembly of complex I and impaired oxidative phosphorylation. Finally, a genome-wide CRISPR-Cas9 loss-of-function screen in differential valine conditions identified several genes, including SLC7A5 and BCL2, whose genetic ablation or pharmacological inhibition synergized with valine restriction to reduce T-ALL growth. Our findings identify tRNA deregulation as a critical adaptation in the pathogenesis of T-ALL and provide a molecular basis for the use of dietary approaches to target tRNA biogenesis in blood malignancies. © 2021. The Author(s), under exclusive licence to Springer Nature Limited.
PMC PMC9116157
PMID 34937946
DOI
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)
SRR13784004 PRJNA704908 Mus musculus Ribo-Seq
SRR13784006 PRJNA704908 Mus musculus Ribo-Seq
SRR13784008 PRJNA704908 Mus musculus Ribo-Seq
SRR13784010 PRJNA704908 Mus musculus Ribo-Seq
SRR13784012 PRJNA704908 Mus musculus Ribo-Seq
SRR13784015 PRJNA704908 Mus musculus Ribo-Seq
SRR13784017 PRJNA704908 Mus musculus Ribo-Seq
SRR13784019 PRJNA704908 Mus musculus Ribo-Seq
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)

ⓘ For more Information on the columns shown here see: About